Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trutek is a healthcare technology company that specializes in the development of patented electrostatic barrier technologies for respiratory protection. The company's flagship product, NasalGuard, is a topical gel that creates an invisible filter around the nasal passages to trap and neutralize airborne allergens, pollutants, and pathogens. Unlike traditional pharmacological treatments, Trutek’s solutions are non-systemic and drug-free, making them suitable for long-term preventative use by a wide demographic, including children and pregnant women. The company’s research focuses on enhancing personal air filtration and reducing the burden of allergic rhinitis and respiratory infections. Trutek has successfully commercialized its technology globally and continues to innovate in the field of preventative nasal health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trutek.